New research is calling for further study on a possible link between COVID-19 jabs and long-term vision issues.

Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.

(Reuters) -British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after ...

Tempus AI's growth is fueled by data services and acquisitions, despite financial risks. Key Q2 results may shape its path to ...

Fiction has been preparing us for an unseen, all knowing CEO for decades. Now technology could make it reality.

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

The newly formed biotech launches with five promising autoimmune candidates, $300 million in funding, and leadership from ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 29th: GDS Holdings Limited GDS: This data center operator from China has a Zacks Rank #1 ...

Africa is building a new vaccine future through strategic investments, skilled workforce development, and local manufacturing ...

List today: Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year ...

We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...